Material Type

• Blood (whole) (1)
• Buffy coat (1)
• Cerebrospinal fluid (1)
• Isolated peripheral blood mononuclear cells (non viable) (2)
• Isolated peripheral blood mononuclear cells (viable) (1)
• Other (1)
• Plasma (single spun) (2)
• Saliva (1)
• Serum (5)
• Stool (1)
• Urine (first morning) (1)
• Urine (random) (2)

Microscopic Assessment

• Affected (1)
• Not applicable (5)

Storage Temperature

• -35°C to -18°C (1)
• -85°C to -60°C (5)
• Liquid nitrogen (1)

Preservation Type

• N/A (1)

Associated Data

• Biomarker datasets (2)
• Clinical records (4)
• Followup records (5)
• Freezer temperature logs (4)
• Microbiological results (1)
• Participant Ethnicity (3)
• Physiological/biochemical measurements (1)
• Pre-analytical data (2)
• Quality indicators (2)
• Survey data (4)
• Treatment records (6)

Timeframe

• Immediate (3)
• 0 - 3 months (5)
• 3 - 6 months (3)
• > 6 months (3)

Participant Count

• 11 - 100 (6)

Sex

• Both sexes (6)

Age Range

• Child (6 - 12 years) (3)
• Adolescent (12 - 18 years) (3)
• Young adult (18 - 40 years) (1)
• Adult (> 40 years) (2)

Biobank Services

• Ability to recontact (1)
• Cell culture (1)
• Immunohistochemistry - staining (1)
• Infectious strain isolation (1)
• Molecular Extractions (2)
• Nucleic acid extraction (3)

Collection Type

• Clinical Trial (1)
• Cohort (2)
• Cross-sectional (2)
• Disease specific (2)

Consent Restriction

• No Commercial restriction (5)
• No Disease area restriction (5)
• No Export restriction (6)
• No Genetic analysis restriction (3)
• No Human genetic analysis restriction (4)
• No restrictions (1)
• No Project specific restriction (6)
• No Scope of use restriction (5)

Collection Status

• Completed (3)
• In progress (3)
• Not-started (1)

Access Condition

• Open to applicants (4)
• Open only through collaboration (2)

Country

• Belgium (1)
• Germany (1)
• Kenya (1)
• Peru (2)
• Switzerland (1)
• United States (1)

County